FDA approves first therapy to reduce vaso-occlusive crisis in sickle cell disease
Lightning Learning: Sickle Cell Disease — EM3
Sickle Cell Disease Awareness - Vaso-occlusive crises are the most common within sickle cell. They occur when sickle shaped red blood cell obstruct blood flow. However, it is not the only type
Clinical Trial Seeking Vaso-Occlusive Sickle Cell Patients to Test Rivipansel
PDF] P-Selectin Blockade in the Treatment of Painful Vaso-Occlusive Crises in Sickle Cell Disease: A Spotlight on Crizanlizumab | Semantic Scholar
Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study | Published in Journal of Health Economics and Outcomes Research
First patient enrolled in Phase 3 trial in sickle cell disease
O5 Initiative - Vaso-Occlusive Crisis is the most common pain episode faced by sickle cell warriors. This crisis affects major areas of the body like the back, legs, knees, arms, chest, and
JCM | Free Full-Text | Sickle Cell Disease: Metabolomic Profiles of Vaso-Occlusive Crisis in Plasma and Erythrocytes
emDOCs.net – Emergency Medicine EducationED Management of Sickle Cell Vaso-occlusive Crises: Myths, Facts, and A Novel Approach to Acute Pain Management - emDOCs.net - Emergency Medicine Education
VASO-OCCLUSIVE CRISIS (VOC): An acute complication of SCD: Recommendations for management. » The Physiologist Perspective
Vicious cycle of vasoocclusive crisis and acute chest syndrome.... | Download Scientific Diagram
Crises in Sickle Cell Disease - ScienceDirect
5 Pearls On Sickle Cell | Core IM Podcast
State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease | SpringerLink
Anemia, Hemolysis, and Vaso-Occlusion Drive SCD Damage
Hypertension Medication Valsartan May Help Prevent Vaso-Occlusive Episodes in Sickle Cell Disease – TIF
Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease - Ifeyinwa Osunkwo, Deepa Manwani, Julie Kanter, 2020
SickleCell911 | -scdaami-
Blockade of placental growth factor reduces vaso-occlusive complications in murine models of sickle cell disease - ScienceDirect